According to Selecta Biosciences's latest financial reports the company's current revenue (TTM) is $34.53 M. In 2022 the company made a revenue of $0.11 B an increase over the years 2021 revenue that were of $85.07 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $34.53 M | -68.83% |
2022 | $0.11 B | 30.21% |
2021 | $85.07 M | 412.6% |
2020 | $16.59 M | 148.57% |
2019 | $6.67 M | 639.42% |
2018 | $0.9 M | 336.23% |
2017 | $0.2 M | -97.44% |
2016 | $8.08 M | 34.47% |
2015 | $6.01 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |